Skip to main content
LYSOGENE logo

LYSOGENE — Investor Relations & Filings

Ticker · LYS ISIN · FR0013233475 LEI · 969500T64RILK1RD0852 PA Professional, scientific and technical activities
Open in API
Filings indexed 254 across all filing types
Latest filing 2023-05-26 Delisting Announcement
Country FR France
Listing PA LYS

About LYSOGENE

https://www.lysogene.com

Lysogene was a clinical-stage biotechnology company that specialized in the research and development of gene therapies for rare, inherited neurodegenerative diseases affecting the central nervous system (CNS). The company's approach focused on delivering a functional copy of a deficient gene directly to the brain to address the root cause of the targeted disorder. Its pipeline included investigational treatments for lysosomal storage diseases such as Sanfilippo syndrome type A (MPS IIIA) and GM1 gangliosidosis. Following clinical and financial challenges, the company initiated judicial liquidation proceedings in 2023.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Delisting Announcement Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a critical corporate event: the conversion of the company's 'redressement judiciaire' (reorganization/restructuring proceedings) into 'liquidation judiciaire' (judicial liquidation) and the subsequent request for delisting from the stock exchange. This is a significant, non-routine corporate announcement concerning the company's legal and operational status, which directly impacts its existence and trading. It is not a standard periodic financial report (like 10-K or IR), an earnings release (ER), or a proxy statement (DEF 14A). Since it is a major, specific regulatory/corporate event announcement that doesn't fit the other specific categories (like M&A, Dividend, Director Dealing), it falls best under the general 'Regulatory Filings' category (RNS) as a significant, mandatory public disclosure, or potentially a 'Delisting Announcement' (DLST). Given the primary focus is the liquidation and subsequent delisting, DLST is highly relevant, but RNS serves as the broader category for mandatory, non-standard regulatory disclosures. However, since 'Delisting Announcement' (DLST) is a specific category provided, and the text explicitly states 'il sera sollicité prochainement auprès d'Euronext la radiation des actions Lysogene' (a request for delisting will soon be made), DLST is the most precise fit for the core action announced, even though it is presented as a press release.
2023-05-26 French
Inside Information / Other news releases
Delisting Announcement Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces a critical corporate event: the conversion of reorganization proceedings into judicial liquidation and the subsequent delisting of shares from Euronext. This type of announcement, detailing a major structural/financial event (liquidation/delisting), is a significant corporate action. While it is a press release, the core subject matter is the delisting and cessation of trading. Among the provided codes, 'DLST' (Delisting Announcement) is the most specific fit for the primary news conveyed, which is the decision leading to the delisting. It is not a standard earnings release (ER), an interim report (IR), or a full annual report (10-K). Since it is a direct announcement of the delisting event, DLST is the appropriate classification.
2023-05-26 English
Informations privilégiées / Autres communiqués
Delisting Announcement Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a specific upcoming event: an audience regarding the potential opening of judicial liquidation proceedings on May 23, 2023. It also mentions that the company will not be able to publish its universal registration document for the year ended December 31, 2022, and that trading remains suspended. This is a time-sensitive, material announcement concerning the company's operational and legal status, which is characteristic of a general regulatory announcement or press release that doesn't fit the specific financial report categories (like 10-K, ER, or IR). Since it is a formal announcement that doesn't fit the more specific categories (like DIV, DIRS, MANG, etc.), the most appropriate fallback category is Regulatory Filings (RNS), as it serves as a general regulatory disclosure.
2023-05-26 French
Inside Information / Other news releases
Legal Proceedings Report Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces a specific upcoming event: a hearing scheduled for May 23, 2023, regarding potential judicial liquidation proceedings. It also mentions that the company will not be issuing its universal registration document for 2022. This is a time-sensitive, material corporate event announcement, typical of a press release intended for immediate public disclosure. Since it is not a full report (like 10-K or IR) but rather an announcement of corporate status and future actions (including a potential delisting), it fits best under the general category for miscellaneous regulatory announcements, which is RNS (Regulatory Filings), as it doesn't fit the more specific categories like DIV, ER, or MANG. Given the short length and the nature of announcing a future event/status update, RNS is the most appropriate classification.
2023-05-26 English
Inside Information / Other news releases
Legal Proceedings Report Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and announces a specific upcoming event: a hearing scheduled for May 23, 2023, regarding potential judicial liquidation proceedings. It also mentions that the company will not be issuing its universal registration document for 2022. This is a time-sensitive, material corporate event announcement, typical of a press release intended for immediate public disclosure. Since it is not a full report (like 10-K or IR) but rather an announcement of corporate status and future actions (including a potential delisting), it fits best under the general category for miscellaneous regulatory announcements, which is RNS (Regulatory Filings), as it doesn't fit the more specific categories like DIV, ER, or MANG. Given the short length and the nature of announcing a future event/status update, RNS is the most appropriate classification.
2023-05-15 English
Informations privilégiées / Autres communiqués
Legal Proceedings Report Classification · 1% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a specific upcoming event: an audience regarding the potential opening of judicial liquidation proceedings on May 23, 2023. It also mentions that the company will not be able to publish its universal registration document for the year ended December 31, 2022, and that trading remains suspended. This is a time-sensitive, material announcement concerning the company's operational and legal status, which is characteristic of a general regulatory announcement or press release that doesn't fit the specific financial report categories (like 10-K, ER, or IR). Since it is a formal announcement that doesn't fit the more specific categories (like DIV, DIRS, MANG, etc.), the most appropriate fallback category is Regulatory Filings (RNS), as it serves as a general regulatory disclosure.
2023-05-15 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.